Article in Archives of microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Joon Ki Kim *Division of Pathogen Resource Management, Center for Public Vaccine Development Support, National Institute of Health, Korea Disease Control and Prevention Agency (KDCA), Cheongju, Republic of Korea.ORCID http://orcid.org/0000-0002-3391-0356
Chi-Hwan Choi *Division of Pathogen Resource Management, Center for Public Vaccine Development Support, National Institute of Health, Korea Disease Control and Prevention Agency (KDCA), Cheongju, Republic of Korea.ORCID http://orcid.org/0000-0002-8560-5230
Dae-Won KimDivision of Pathogen Resource Management, Center for Public Vaccine Development Support, National Institute of Health, Korea Disease Control and Prevention Agency (KDCA), Cheongju, Republic of Korea.ORCID http://orcid.org/0000-0003-0917-1511
Su Yeon KimDivision of Pathogen Resource Management, Center for Public Vaccine Development Support, National Institute of Health, Korea Disease Control and Prevention Agency (KDCA), Cheongju, Republic of Korea.ORCID http://orcid.org/0000-0003-4474-9702
Kyu Jam HwangDivision of Bacterial Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju, Republic of Korea.ORCID http://orcid.org/0000-0001-9499-8059
Woo-Kon LeeDepartment of Microbiology, School of Medicine, Gyeongsang National University, Jinju, Republic of Korea.
Min Kyoung ShinDepartment of Microbiology, School of Medicine, Gyeongsang National University, Jinju, Republic of Korea.
Myunghwan JungDepartment of Microbiology, School of Medicine, Gyeongsang National University, Jinju, Republic of Korea.
Young Sill ChoiDivision of Pathogen Resource Management, Center for Public Vaccine Development Support, National Institute of Health, Korea Disease Control and Prevention Agency (KDCA), Cheongju, Republic of Korea. yschoi83@korea.kr.ORCID http://orcid.org/0000-0001-7615-9884
Funding
Korea National Institute of Health 2017-NG45004-00
6 · The paper itself
Abstract
A Gram-positive, aerobic, rod-shaped bacterium, designated as strain 1605-214
Indexed as
Fatty AcidsPhospholipidsBacillalesBacterial Typing TechniquesDNA, BacterialHumansPhylogenyRepublic of KoreaRNA, Ribosomal, 16SSequence Analysis, DNAVitamin K 2DNA, BacterialFatty AcidsPhospholipidsRNA, Ribosomal, 16SVitamin K 2Cohnella cholangitidisComplete genomeHuman bloodNovel speciesTaxonomy
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Cohnella cholangitidis sp. nov., a novel species of the genus Cohnella isolated from a clinical specimen in Korea. · full record | OpenQuestion